baber/WOPTO huggingface dataset:
Patent CA-2600579-A1 (CA)
Title: Systemes et methodes de controle de l'information correspondant a des sessions de communication
Inventor: CALAHAN MARC
IPC: H04L12/26
Filed: 2007-09-28
Abstract: L'invention porte sur des systèmes et des méthodes permettant le contrôle de l'information correspondant à des sessions de communication. Une méthode exemplaire comprend la réception d'information correspondant aux sessions de communication; le stockage de l'information dans un stockage à long terme; l'extraction d'une première partie de l'information provenant du stockage à long terme; la population d'une base de données avec la première partie de l'information de façon que la partie de l'information est stockée dans la base de données en plus d'être stockés dans le stockage à long terme; la détermination d'information supplémentaire correspondant à la session de communication est exigée pour utilisation; et l'extraction d'une partie supplémentaire de l'information provenant du stockage à long terme.
Patent CA-2601937-A1 (CA)
Title: Implementing data-compatibility-based version scheme
Inventor: GORING BRYAN R
IPC: H04Q7/32
Filed: 2005-09-06
Abstract: A versioning schema enforced by the application development environment enables the runtime environment of a terminal device to evaluate a software update to identify potential compatibility issues and control installation of the update. The versioning schema includes a respective field for each one of a plurality of aspects of the application and defines an initial value of each field when an initial application load is released. For each successive software update affecting the application, the method involves identifying each aspect of the application affected by the software update and incrementing a value of the respective field of each identified aspect. The version number can be in the form D.M.F where D, M and F are incremented in response to changes in the application relating to data components, message components and features.
Patent CA-2603826-A1 (CA)
Title: Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
Inventor: GRIERSON DAVID
IPC: A61P35/00
Filed: 2006-04-04
Abstract: The present invention relates to novel compounds selected from substituted oxazole derivatives of formula (I) that selectively modulate, regulate, and/or inhibit signal transduction mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative, metabolic, allergic, and degenerative disorders. More particularly, these compounds are potent and selective c-kit, bcr-abl and Fit-3 inhibitors.
Patent CA-2607987-A1 (CA)
Title: Process for improving the thermal and light stability of polyesters
Inventor: MUELLER DANIEL
IPC: C08K5/1539
Filed: 2006-05-10
Abstract: The present invention describes a process for improving the thermal and light stability of polyesters, especially polyester fibers, which comprises adding to the polyesters a chain extender. Especially preferred chain extenders are dianhydrides, alcohols and hindered phenolic aromatic phosphates or mixtures thereof.
Patent CA-2608120-A1 (CA)
Title: Pharmaceutical composition for the inhibition of lipogenesis comprising a regulator of prp19 expression
Inventor: LEE HYOUNG-HO
IPC: A61K31/7105
Filed: 2006-05-02
Abstract: The downregulation of PRP 19 (precursor RNA processing 19) protein expression results in effectively reducing the expression of SCD1 (stearyl CoA desaturase-1), the key lipogenic enzyme, and its down-stream triacylglycerol synthesis enzymes, DGAT-1 (diacyglycerol acyltransferase-1) and GPAT (glycerol-phosphate acyltransferase), as well as the intracellular content of neutral lipids, the major target for treating obesity.
Patent CA-2610742-A1 (CA)
Title: Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders
Inventor: KAUPMANN KLEMENS
IPC: C07D239/48
Filed: 2006-06-23
Abstract: The invention relates to novel heterocyclic compounds of the formula (I) in free base form or in acid addition salt form, in which R1, R2, R3, R4 and A  are as defined in the specification, to their preparation, to their use as medicaments for the treatment of certain nervous system disorders and to medicaments comprising them.
Patent CA-2611094-A1 (CA)
Title: Air spring assembly and method
Inventor: TAYLOR ROBERT
IPC: F16F9/04
Filed: 2006-05-05
Abstract: An air spring assembly (100) including a first end member (102) that includes a side wall (122), and a second end member (104) spaced from the first end member. A flexible sleeve (106) includes a sleeve wall (132) and opposing open ends (134, 136) secured on the first and second end members. First and second retaining member (110 and 112 or 114 and 116) are used to secure one open end of the flexible sleeve on the associated end member. A method (200) is also disclosed.
Patent CA-2611179-A1 (CA)
Inventor: REDMANN FRANK
IPC: C03C17/36
Filed: 2006-06-02
Abstract: The invention relates to low-E layered systems containing at least one metal layer consisting of gold, silver or copper, which is embedded between layers of transparent metal oxides. According to the invention, the layered system is modified in the vicinity of the coloured structures to form a material configuration, in which the gold, silver and copper are present in the form of nanoparticles embedded in a matrix, which is formed from the substances of the layered system that were originally present in layers.
Patent CA-2611917-A1 (CA)
Title: Injection
Inventor: INOUE TOMOKO
IPC: A61P29/00
Filed: 2006-06-12
Abstract: In the case of storing and supplying an injection containing a 2-[(2-pyridyl)methylsulfinyl]benzimidazole type compound in a plastic container in addition to a glass container, an injection having been improved in stability and solubility and showing excellent qualities without forming any insoluble foreign matters or insoluble microparticles can be obtained by using cyclodextrin or its derivative together.
Patent CA-2614769-A1 (CA)
Title: Lyase enzymes, nucleic acids encoding them and methods for making and using them
Inventor: WEINER DAVID
IPC: C12N9/88
Filed: 2006-03-10
Abstract: This invention provides polypeptides having lyase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In one aspect, the invention is directed to polypeptides having ammonia lyase activity, e.g., phenylalanine ammonia lyase, tyrosine ammonia lyase and/or histidine ammonia lyase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural and industrial contexts.
Patent CA-2615987-A1 (CA)
Title: Liquid natural gas processing
Inventor: REDDICK KENNETH
IPC: F25J3/02
Filed: 2006-07-25
Abstract: A process for the recovery of natural gas liquids (NGL) from liquefied natural gas (LNG) is disclosed. The LNG feed stream (1) is subjected to a two stage separation process where the bottoms (11) from the first stage separation (S) containing C2+ hydrocarbons is split into two portions (14,15), with one portion (14) being heated (4) and used as a reflux (31) during the second stage separation (16) to recover the NGL product (19).
Patent CA-2617620-A1 (CA)
Inventor: WEINBERGER RON
IPC: A61L2/20
Filed: 2006-08-04
Abstract: A nebulant suitable for sterilization comprising finely divided liquid droplets suspended in a gas, said droplets including a solute, which is advantageously hydrogen peroxide and a solvent, for example water, wherein the droplets have a concentration of greater than 60 wt% of solute and an average diameter of less than 1.0 micron, preferably less than 0.8 microns.  Sterilization using the nebulant may be carried out in suitably adapted apparatus by nebulising a solution comprising a sterilizing agent in a solvent to form a nebulant of finely divided particles of the solution in a gas stream, said solution including a solvent having a lower boiling point than the sterilizing agent; subjecting the nebulant to energy of a kind and for a duration sufficient to vaporize solvent in preference to sterilizing agent, whereby to increase the concentration of the agent in the nebulant particles;  removing the solvent vaporized from the gas stream at or above atmospheric pressure and, if necessary, cooling the nebulant to below 70~ C; and exposing a surface to be sterilized to the nebulant of concentrated sterilizing agent for a time sufficient to sterilize the surface.
Patent CA-2620946-A1 (CA)
Inventor: GUO LIHE
IPC: A61P25/16
Filed: 2006-06-23
Abstract: The present invention provides a population of human amniotic cells comprising lentiviral vectors with at least one exogenous gene element and methods for making such cells. The cells of the invention can be used for treating diseases such as those related to neurologic disorders including, for example, cerebral ischemia, cerebral vascular disease, central nervous system injuries, genetic diseases of the nervous system, degenerative diseases of the cerebral nervous system, tumors of the cerebral nervous system and combinations thereof.
Patent CA-2621583-A1 (CA)
Inventor: GUERQUIN BERNARD
IPC: A61F2/00
Filed: 2006-09-13
Abstract: The invention concerns a device for preventing female stress incontinence designed to be arranged in the vagina, comprising a proximal part (12) extending between a free end and a second end, configured to be undeformable under pressure and to be placed in the suburethral region of the vagina, and a distal part (14) extending the second end of the proximal part (12), made of a material reversibly deformable under pressure, and designed to be placed in the subvesical region of the vagina. The invention is characterized in that the distal part (14) delimits a closed outline which receives the weight of the bladder and transforms same into an ascending force acting on the urethra.
Patent CA-2621811-A1 (CA)
Inventor: MIYAKE YOSHIMASA
IPC: A61P1/16
Filed: 2006-09-21
Abstract: The invention provides an enhancer for cholinesterase. An enhancer comprising Gam Arabic as an active ingredient is useful for preventing and/or treating a decreased cholinesterase activity due to liver damage or inhibition of cholinesterase as a side effect of various agents.
Patent CA-2622640-A1 (CA)
Title: Improved process for the preparation of ciclesonide
Inventor: ROSSETTO PIERLUIGI
IPC: C07J71/00
Filed: 2006-11-02
Abstract: Provided is a process for increasing the 22R/22S epimeric ratio of ciclesonide.
Patent CA-2624001-A1 (CA)
Title: Method of diagnosis of tuberculosis related immune restoration syndrome (irs)
Inventor: MARTINEZ VALERIE
IPC: G01N33/50
Filed: 2006-09-07
Abstract: The present invention relates to a method and kit of diagnosis of Immune Restoration Syndrome associated with tuberculosis (TB-IRS) in patients infected with tuberculosis (TB) as well as in HIV co-infected patients comprising detecting an acute increase in Th1 response following exposure to mycobacterial extract, referred as tuberculin or PPD (Purified Protein Derivative) as well as to the 16kDa protein, but not to ESAT-6 or CFP-10, two antigens from mycobacterium tuberculosis.
Patent CA-2624967-A1 (CA)
Inventor: DUGAN REGINA E
IPC: B32B27/12
Filed: 2006-10-05
Abstract: A folly integrated portable screening system (2) includes a main housing (4) and a contact pad (94). The contact pad (94) is removably positioned in the main housing (4) and covered by at least one sample sheet (104). The contact pad (94) is preferably constituted by a cylindrical baton which carries a roll (103) of sample collection sheets (104). A test subject interacts with the contact pad (94), leaving a trace sample on the sample collection sheet (104).  The contact pad (94) is then placed within the main housing (4) and the trace sample is exposed to a test medium designed to interact with a specific analyte of interest potentially present in the trace sample. After exposure to the test medium, the sample sheet (104) is subjected to a testing mechanism which exposes any interaction between the test medium and the analyte of interest to produce a test result.
Patent CA-2625540-A1 (CA)
Title: Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
Inventor: TIAN FENG
IPC: C07K1/02
Filed: 2006-11-08
Abstract: Disclosed herein are accelerants for the formation of oxime-containing compounds from the reaction of a carbonyl-containing compound and a hydroxylamine-containing compound. The oxime-containing compound, the carbonyl-containing compound and the hydroxylamine-containing compound can each be a non-natural amino acid or a non-natural amino acid polypeptide. Also disclosed is the use of such accelerants to form oxime-containing compounds, the resulting oxime-containing compounds, and reaction mixtures containing such accelerants.
Patent CA-2625713-A1 (CA)
Title: Gestion de ressources amrs
Inventor: JI TINGFANG
IPC: H04L27/26
Filed: 2006-10-27
Abstract: Un procédé d'affectation de ressources dans un environnement de communications sans fil consiste à recevoir un mappage effectué entre un premier port de saut et une plage de fréquence et à déterminer s'il faut mapper un deuxième terminal d'accès sur un deuxième port de saut qui est mappé sur au moins la même plage de fréquence pendant une instance sensiblement similaire dans le temps, la détermination étant réalisée en fonction de caractéristiques relatives au premier terminal d accès associé au premier port de saut. Le procédé peut également consister à déterminer que le premier terminal d'accès est un candidat pour utiliser l'accès multiple par répartition spatiale (AMRS) et à mapper le deuxième port de saut puis à associer le deuxième terminal d'accès au deuxième port de saut lorsque le deuxième terminal d'accès est également un candidat pour utiliser AMRS.
Patent CA-2625867-A1 (CA)
Title: Processes for preparation of maytansinol
Inventor: CHARI RAVI V J
IPC: C07D491/12
Filed: 2006-11-08
Abstract: The present invention describes the preparation of maytansinol by methods that minimize processing steps, and reduce solvent volumes, making the process more efficient, and scaleable. This process comprises a step of converting bridged acetals of maytansinol to maytansinol. The simplified processing also aids in lowering the potential for human exposure to chemicals. Also provided is an isolated C3 to C9 bridged acetal of maytansinol.
Patent CA-2626697-A1 (CA)
Title: Apparatus for locating an ostium of a vessel
Inventor: DREHER JAMES H
IPC: A61F2/82
Filed: 2006-09-29
Abstract: Apparatus (10) for locating an ostium of a branch vessel includes a delivery-catheter (12) having a distal end (16) sized for introduction into the branch, and locator elements (50) including first ends (52) fixed to the distal end (16) and second ends (54) free from the distal end (16). The locator elements (50) are compressible from a transverse, deployed condition to an axial, contracted condition, wherein the second ends (54) are disposed proximal to the first ends (52). The catheter (12) may be used to deliver a stent (40) into the branch with the expanded locator element (50) facilitating positioning the stent (40).
Patent CA-2626908-A1 (CA)
Title: Barriere thermique deposee directement sur superalliages monocristallins
Inventor: LE BIAVANT KRISTELL
IPC: C23C14/08
Filed: 2008-03-28
Abstract: L'invention concerne le domaine des superalliages revêtus d'une barrière thermique. Sur un superalliage (10) monocristallin de composition en masse de 3,5 à 7,5% Cr, 0 à 1,5% Mo, 1,5 à 5,5% Re, 2,5 à 5,5% Ru, 3,5 à 8,5%W,5 à 6,5% Al, 0 à 2,5% Ti,4,5 à 9% Ta,0,08 à 0,12% Hf, 0,08 à 0,12% Si, le complément à 100% étant constitué par Ni et les impuretés éventuelles, on dépose directement une zircone (20) stabilisée avec au moins un oxyde d'un élément choisi dans le groupe constitué des terres rares, ou avec une combinaison d'un oxyde de tantale et d'au moins un oxyde de terre rare, ou avec une combinaison d'un oxyde de niobium et d'au moins un oxyde de terre rare.
Patent CA-2629788-A1 (CA)
Title: Propylene-ethylene copolymers and process for their preparation
Inventor: MORINI GIAMPIERO
IPC: C08F210/02
Filed: 2006-11-10
Abstract: Propylene-ethylene copolymers are flexible and show a very good balance between softness and mechanical properties in their crude state are obtained by solution polymerization in the presence of Ziegler-Natta catalysts. The said copolymers comprise from 10 to 50% wt of ethylene and are characterized by: product of the comonomer reactivity ratio r1.r2<=1.5; absence of 2,1 propylene insertions and tensile strength at break higher than 4 Mpa.
Patent CA-2633625-A1 (CA)
Title: Retractable winshield for a boat
Inventor: GODFREY PHILIP
IPC: B60J1/06
Filed: 2006-09-15
Abstract: A boat has a hull and a deck. The deck has a forward passenger area and a rearward passenger area. A passageway allows for communication between the forward passenger area and the rearward passenger area. A door is disposed on the deck for selectively closing the passageway between the forward passenger area and the rearward passenger area. A windshield is movable between a first position where the windshield extends a first distance vertically above the top of the door and a second position where the windshield extends a second distance vertically above the top of the door.  In another aspect, a windshield is movable between a first position where the windshield extends a first distance vertically above the top of a console and a second position where at least a portion of the windshield extends a second distance vertically below the top of the console.
Patent CA-2633803-A1 (CA)
Inventor: LAI HUNG-SEN
IPC: A61K31/69
Filed: 2006-12-15
Abstract: The invention provides compounds and methods for inhibiting proteases. One aspect of the invention features prosoft inhibitors which react with an activating protease to release an active inhibitor moiety in proximity to a target protease. In certain instances, compounds inhibit proteasomes and/or post-proline cleaving enzymes (PPCE), such as dipeptidyl peptidase IV.  The compounds of the invention provide a better therapeutic index, owing in part to reduced toxicity and/or improved specificity for the targeted protease.
Patent CA-2634110-A1 (CA)
Title: Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
Inventor: REITZ ALLEN B
IPC: A61P25/32
Filed: 2006-12-19
Abstract: The present invention is a method for the treatment of alcohol abuse and / or addiction comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and / or formula (II) as herein defined.
Patent CA-2637494-A1 (CA)
Title: Leaf spring track latch
Inventor: LAPINGCAO EPHRAIM MARK DEDIOS
IPC: B60N2/07
Filed: 2007-02-27
Abstract: A seat track assembly is provided for mounting a seat to a vehicle floor. A  fixed track is mounted to the floor and a movable track is fixedly secured to the seat and slidably coupled to the fixed track. A latch is operatively coupled to the movable track for selectively engaging the fixed track. A towel bar is operatively coupled to the latch for actuating the latch between a locked position coupled with the fixed track to prevent sliding movement between the fixed and movable tracks and an unlocked position decoupled from the fixed track to allow sliding movement between the fixed and movable tracks. A leaf spring extending between the movable track and the latch biases the latch into the locked position and permits resilient movement of the latch along a linear path between the locked and unlocked positions in response to pivotal movement of the towel bar.
Patent CA-2639364-A1 (CA)
Inventor: WOODS SCOTT L
IPC: B60R3/00
Filed: 2008-09-05
Abstract: The present invention is a step load bracket having a substantially horizontal portion and a substantially vertical portion connected to the substantially horizontal portion. The present invention also includes at least one support member connected to the substantially vertical portion and the substantially horizontal portion. The support member provides support for a body component of a vehicle having a step, such as a fascia, when a load is applied to the fascia in a vertical direction, but has pre-determined crush characteristics when the fascia suffers from an impact load in a horizontal direction, such as during a rear-end collision.
Patent CA-2645300-A1 (CA)
Title: Wireless communication method and system for performing handover between two radio access technologies
Inventor: SHAHEEN KAMEL M
IPC: H04W92/24
Filed: 2007-03-07
Abstract: The present invention relates to a method and apparatus for performing handover between a universal mobile telecommunication system (UMTS) terrestrial radio access network (UTRAN), and an evolved-UTRAN (E-UTRAN) based system. The wireless communication system includes a UTRAN, an E-UTRAN, a 2G/3G core network, and long term evolution (LTE) core network, and at least one wireless transmit/receive unit (WTRU) including an LTE element and ad 2G/3G element. According to the present invention the WTRU shall be able to handover a call initiated on the UTRAN to the E-UTRAN, and visa versa. The 2G/3G core network and the LTE core network are linked by a Gn interface.
Patent CA-2649961-A1 (CA)
Inventor: DULL GARY MAURICE
IPC: A61P25/28
Filed: 2007-05-08
Abstract: Polymorph forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4- penten-2-amine p-hydroxybenzoate, and methods for their preparation, pharmaceutical composition containing said polymorph(s) and use, are disclosed. The polymorphs can be administered to patients susceptible to or suffering from conditions and disorders, such as central nervous system disorders, to treat and/or prevent such disorders.
Patent CA-2650983-A1 (CA)
Title: Improved oxidation process with enhanced safety useful in the manufacture of moxidectin
Inventor: CARACO MARCO
IPC: C07D493/22
Filed: 2007-06-15
Abstract: The present invention provides a safe and effective process for the selective oxidation with stabilised 2-iodoxybenzoic of a 5-O-protected-LLF-28249-.alpha. compound to the corresponding 23-keto compound of formula (I), wherein R is a protecting group. The present invention also provides the use of the selective oxidation process in the manufacture of moxidectin.
Patent CA-2652937-A1 (CA)
Title: Engrais a base d'uree a faible croissance cristalline
Inventor: THOMPSON HAROLD
IPC: A01N33/02
Filed: 2007-05-29
Abstract: La présente invention concerne des compositions et des procédés permettant d'inhiber l'agglutination ou le mottage dans des engrais contenant de l'urée en réduisant le rapport d'aspect des cristaux qui se forment dans l'engrais jusqu'à un niveau suffisant pour éliminer efficacement l'agglutination dans un engrais traité.
Patent CA-2656024-A1 (CA)
Inventor: HARGROVE THOMAS H
IPC: G06F17/30
Filed: 2007-06-25
Abstract: A system that facilitates data processing includes a receiver component that receives an SQL query. A partitioning component partitions the SQL query into multiple tasks and provides the tasks to multiple cluster nodes for processing. The system enables very large amounts of data (e.g., multiple terabytes) to be quickly prepared for analytical processing, such as for use in connection with a search engine, an advertisement provision system, etc.